To study mechanisms of therapeutic resistance in pre-LSCs, we have utilized the Cd2-Lmo2-transgenic (Lmo2Tg) mouse model of T-cell acute lymphoblastic leukemia (T-ALL)9. This evidence concerns the gene LMO2 and acute lymphoblastic leukemia.